Effect of Dutasteride on Intraprostatic Androgen Levels in Men With Benign Prostatic Hyperplasia or Prostate Cancer

The Influence of Finasteride on the Development of Prostate Cancer

Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

Medicine, Endocrinology, Pharmacology +14

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia

John D. McConnell, Reginald C. Bruskewitz, Patrick Walsh et al. · New England Journal of Medicine · 1998 · 1.1K citations · Full text

Medicine, Surgery, Urology +17

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

Claus G. Roehrborn, Peter Boyle, J. Curtis Nickel et al. · Urology · 2002 · 734 citations

Medicine, Endocrinology, Pharmacotherapy +11

Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor

Richard V. Clark, David Hermann, Glenn R. Cunningham et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 460 citations

Life Sciences, Pharmacology, Pharmacotherapy +15

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.

John D. McConnell, J D Wilson, Fredrick W. George et al. · The Journal of Clinical Endocrinology & Metabolism · 1992 · 307 citations

Medicine, Endocrinology, Pharmacotherapy +17